(Q33793636)

29 July 2017

1 reference

title

Bradykinin antagonists: present progress and future prospects (English)

1 reference

29 July 2017

Stewart JM

1

1 reference

29 July 2017

Gera L

2

1 reference

29 July 2017

York EJ

3

1 reference

29 July 2017

Chan DC

4

1 reference

29 July 2017

Bunn P

5

1 reference

29 July 2017

publication date

1 September 1999

1 reference

29 July 2017

1 reference

29 July 2017

volume

43

1 reference

29 July 2017

issue

2-3

1 reference

29 July 2017

page(s)

155-161

1 reference

Comparative profile of novel potent bradykinin antagonists at human B1 and B2 receptors

29 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2899%2900102-2

7 January 2021

Novel bradykinin antagonist dimers for the treatment of human lung cancers

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2899%2900102-2

7 January 2021

A new class of bradykinin antagonists: synthesis and in vitro activity of bissuccinimidoalkane peptide dimers

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2899%2900102-2

7 January 2021

New bradykinin antagonists having very high potency at B1 receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2899%2900102-2

7 January 2021

The nonpeptide B2 receptor antagonist FR173657: inhibition of effects of bradykinin related to its role in nociception

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2899%2900102-2

7 January 2021

In vivo pharmacological profile of novel, potent, stable BK antagonists at B1 and B2 receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2899%2900102-2

7 January 2021

Hoe 140 a new potent and long acting bradykinin-antagonist: in vitro studies

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2899%2900102-2

7 January 2021

Characterization of FR173657, a novel nonpeptide B2 antagonist: in vitro and in vivo studies

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2899%2900102-2

7 January 2021

Probing the bradykinin receptor: mapping the geometric topography using ethers of hydroxyproline in novel peptides

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2899%2900102-2

7 January 2021

Role of bradykinin in microbial infection: enhancement of septicemia by microbial proteases and kinin

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2899%2900102-2

7 January 2021

Bradykinin and nitric oxide in infectious disease and cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2899%2900102-2

7 January 2021

New short-chain analogs of a substance-P antagonist inhibit proliferation of human small-cell lung-cancer cells in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2899%2900102-2

7 January 2021

Receptors for bradykinin in rabbit aortae

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2899%2900102-2

7 January 2021

Conversion of kinins and their antagonists into B1 receptor activators and blockers in isolated vessels

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2899%2900102-2

7 January 2021

The kallikrein/kinin system and kinin antagonists in trauma

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2899%2900102-2

7 January 2021

Design of potent non-peptide competitive antagonists of the human bradykinin B2 receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2899%2900102-2

7 January 2021

Further evidence of bradykinin involvement in septic shock: reduction of kinin production in vivo and improved survival in rats by use of polymer tailored SBTI with longer t1/2.

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2899%2900102-2

7 January 2021

A new class of bradykinin antagonists containing indanylglycine

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2899%2900102-2

7 January 2021

Competitive antagonists of bradykinin

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2899%2900102-2

7 January 2021

Oral activity of peptide bradykinin antagonists following intragastric administration in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2899%2900102-2

7 January 2021

Hoe 140 a new potent and long acting bradykinin-antagonist: in vivo studies

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2899%2900102-2

7 January 2021

10.1016/S0162-3109(99)00102-2

Identifiers

DOI

1 reference

29 July 2017

1 reference